Influenza A/B Antigen | Beta Lifescience

Influenza A/B Antigen

Home/Viral Antigens/Influenza A/B Antigen

Influenza A/B Antigen

Influenza (flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness. Serious outcomes of flu infection can result in hospitalization or death. Some people, such as older people, young children, and people with certain health conditions, are at high risk of serious flu complications. There are two main types of influenza (flu) virus: Types A and B. The influenza A and B viruses that routinely spread in people (human influenza viruses) are responsible for seasonal flu epidemics each year.

What’s new in 2020 flu season?

WHO released the Recommended composition of influenza virus vaccines for use in the 2020 southern hemisphere influenza season

It is recommended that trivalent influenza vaccines for use in the 2020 southern hemisphere influenza season contain the following:

an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A/South Australia/34/2019 (H3N2)-like virus; and
a B/Washington/02/2019-like (B/Victoria lineage) virus.

Beta Lifescience provides the following 2020 seasonal flu HA proteins

BLIT-1031	Recombinant influenza hemagglutinin HA (A/Brisbane/02/2018)(H1N1)
BLIT-1032	Recombinant influenza hemagglutinin HA1 (A/Brisbane/02/2018)(H1N1)
BLIT-1033	Recombinant influenza hemagglutinin HA (A/South Australia/34/2019)(H3N2)
BLIT-1034	Recombinant influenza hemagglutinin HA1 (A/South Australia/34/2019)(H3N2)
BLIT-1035	Recombinant influenza hemagglutinin HA (B/Washington/02/2019)
BLIT-1036	Recombinant influenza hemagglutinin HA1 (B/Washington/02/2019)
BLIT-1037	Recombinant influenza hemagglutinin HA (B/Phuket/3073/2013)
BLIT-1038	Recombinant influenza hemagglutinin HA1 (B/Phuket/3073/2013)

View all the Influenza A/B Antigen As below

Cat No.	Product Name	Source	Detail	Inquiry
BLIT-0335	Recombinant HA1 (A/Iowa/32/2016)(H1N2)	HEK293
BLIT-0336	Recombinant HA1 (A/Netherlands/3315/2016)(H1N1)	HEK293
BLIT-0337	Recombinant HA1 (A/Hunan/42443/2015)(H1N1)	HEK293
BLIT-0338	Recombinant HA(ΔTM)(A/Singapore/INFIMH-16-0019/2016)(H3N2)	HEK293
BLIT-0339	Recombinant HA1(A/Hong Kong/125/2017(H7N9)	HEK293
BLIT-0340	Recombinant HA1(A/Singapore/INFIMH-16-0019/2016)(H3N2)	HEK293
BLIT-0341	Recombinant HA1 (A/chicken/Ghana/20/2015(H5N1))	HEK293
BLIT-0345	Recombinant HA1(B/Colorado/06/2017)	HEK293
BLIT-0348	Recombinant NA(A/Shanghai/2/2013(H7N9))	HEK293
BLIT-0350	Recombinant HA1(A/Bolivia/559/2013)(H1N1)	HEK293
BLIT-0351	Recombinant HA(∆TM)(B/Colorado/06/2017)	HEK293
BLIT-0352	Recombinant HA(∆TM)(A/Hawaii/19/2007(H1N1))	HEK293
BLIT-0353	Recombinant HA1 (H1N1/PR8/34)	HEK293
BLIT-0354	Recombinant HA1 (H1N1)(A/Solomon Islands/3/2006)	HEK293
BLIT-0355	Recombinant HA(ΔTM)(H1N1/A/Solomon Islands/3/2006)	HEK293
BLIT-0356	Recombinant HA(Head Region)(A/Brisbane/59/2007)	HEK293
BLIT-0357	Recombinant HA1(H1N1)(A/Brisbane/59/2007)	HEK293
BLIT-0358	Recombinant HA(ΔTM)(H1N1) (A/Brisbane/59/2007)	HEK293
BLIT-0359	Recombinant HA1(H1N1)(A/WS/33)	HEK293
BLIT-0360	Recombinant HA1(A/South Carolina/1/18(H1N1))	HEK293
BLIT-0361	Recombinant HA(ΔTM)(A/South Carolina/1/18/(H1N1))	HEK293
BLIT-0362	Recombinant HA1(A/Bel/1942(H1N1))	HEK293
BLIT-0363	Recombinant HA1(A/USSR/92/77(H1N1))	HEK293
BLIT-0364	Recombinant HA1(A/Albany/12/1951(H1N1))	HEK293
BLIT-0365	Recombinant HA1(A/Phila/1935(H1N1))	HEK293
BLIT-0366	Recombinant HA1(A/Memphis/1/1987(H1N1))	HEK293
BLIT-0367	Recombinant HA1(H1N1)(A/New Caledonia/20/99)	HEK293
BLIT-0368	Recombinant HA(ΔTM)(H1N1/A/New Caledonia/20/99)	HEK293
BLIT-0369	Recombinant HA(ΔTM)(H2N2)(A/Canada/720/05)	HEK293
BLIT-0370	Recombinant HA(ΔTM)(A/Japan/305/1957(H2N2))	HEK293
BLIT-0371	Recombinant HA1 (H2N2)(A/Canada/720/05)	HEK293
BLIT-0372	Recombinant H3(∆TM)(H3N2)(A/Johannesburg/33/94)	HEK293
BLIT-0381	Recombinant HA1 (H3N2)(A/Wisconsin/67/X-161/2005)	HEK293
BLIT-0382	Recombinant HA(ΔTM)(H3N2/ Wisconsin/67/X-161/2005)	HEK293
BLIT-0384	Recombinant HA1(H3N2)(A/VICTORIA/210/2009)	HEK293
BLIT-0385	Recombinant HA(∆TM)(H3N2)(A/VICTORIA/208/2009)	HEK293
BLIT-0386	Recombinant HA1(H3N2)(A/Brisbane/10/2007)	HEK293
BLIT-0387	Recombinant HA(ΔTM)(H3N2)(A/Brisbane/10/2007)	HEK293
BLIT-0388	Recombinant HA(ΔTM)(A/Aichi/2/1968(H3N2))	HEK293
BLIT-0389	Recombinant HA(∆TM)(H3N2/Wisconsin/15/2009)	HEK293
BLIT-0390	Recombinant HA(∆TM)(H3N2/Perth/16/2009)	HEK293
BLIT-0394	Recombinant H3(∆TM)(H3N2)(A/Wuhan/359/95)	HEK293
BLIT-0395	Recombinant HA1 (H3N2)(A/Wyoming/3/03)	HEK293
BLIT-0396	Recombinant HA1(A/Iowa/08/2011(H3N2))	HEK293
BLIT-0397	Recombinant HA1(A/Minnesota/09/2010(H3N2))	HEK293
BLIT-0398	Recombinant HA1(A/Kansas/13/2009(H3N2))	HEK293
BLIT-0399	Recombinant HA1(A/Pennsylvania/14/2010(H3N2))	HEK293
BLIT-0400	Recombinant HA1(A/Ontario/RV1273/2005(H3N2))	HEK293
BLIT-0401	Recombinant HA(ΔTM)(H3N2/Wyoming/3/03)	HEK293
BLIT-0402	Recombinant HA (A/Egypt/2321-NAMRU3/2007 (H5N1))	HEK293

<1234567>